Kerui Gene Biotechnology key facts
- Manufacturer of biotechnology-based products designed for genetic analysis purposes.
- Notable investors include Bengbu Investment Group, Beijing Shengshi Hongming Investment Fund Management.
- Status: Privately Held (backing).
Who backs Kerui Gene Biotechnology
2- ·Watch Kerui Gene Biotechnology: the Monday email on marks, rounds and moves
Kerui Gene Biotechnology funding rounds
No funding rounds for Kerui Gene Biotechnology are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Kerui Gene Biotechnology investors
2 investors are on record for Kerui Gene Biotechnology, including Bengbu Investment Group and Beijing Shengshi Hongming Investment Fund Management.
About Kerui Gene Biotechnology
Manufacturer of biotechnology-based products designed for genetic analysis purposes. The company offers testing methods, laboratory automation, and bioinformatics tools with capabilities for sample processing, data interpretation, and clinical research support, enabling healthcare and life sciences markets to access reliable diagnostic insights, improved efficiency in genetic screening workflows, and enhanced opportunities for precision medicine applications through comprehensive genomic data management and analysis.
- Sector
- Healthcare
- HQ
- Bangbu, China
- Founded
- 2023
- Employees
- 7
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.
Kerui Gene Biotechnology doesn't have a valuation on record yet — one is published once a priced round, a reported valuation, fund marks, or secondary prints surface in our sources. The rest of the record below builds toward it.